CPD-1

Source: Wikipedia, the free encyclopedia.
CPD-1
Legal status
Legal status
  • In general: uncontrolled
Identifiers
  • (3S)-3-Methyl-1-[4-(trifluoromethyl)-1-benzofuran-7-yl]piperazine
JSmol)
  • C[C@H]1CN(CCN1)C2=C3C(=C(C=C2)C(F)(F)F)C=CO3
  • InChI=1S/C14H15F3N2O/c1-9-8-19(6-5-18-9)12-3-2-11(14(15,16)17)10-4-7-20-13(10)12/h2-4,7,9,18H,5-6,8H2,1H3/t9-/m0/s1
  • Key:RZSIBGYUCGYDKG-VIFPVBQESA-N

CPD-1 (LS-193743) is a

affinity and full agonist efficacy at the 5-HT2C subtype, and lower affinity and partial agonist action at the 5-HT2A and 5-HT2B subtypes.[1][2]

See also

References

This page is based on the copyrighted Wikipedia article: CPD-1. Articles is available under the CC BY-SA 3.0 license; additional terms may apply.Privacy Policy